A NOVEL CYP2D6 ALLELE WITH AN ABOLISHED SPLICE RECOGNITION SITE ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE

被引:44
作者
MAREZ, D
SABBAGH, N
LEGRAND, M
LOGUIDICE, JM
BOONE, P
BROLY, F
机构
[1] Laboratoire de Biochimie et Biologie Moléculaire de l’Hôpital Calmette, Centre Hospitalier Régional et Universitaire de Lille, Lille, 59037, Bd. J. Leclercq
来源
PHARMACOGENETICS | 1995年 / 5卷 / 05期
关键词
CYP2D6; PCR-SSCP; PHARMACOGENETIC; DEBRISOQUINE; GENOTYPING;
D O I
10.1097/00008571-199510000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A novel loss-of function allele of the CYP2D6 gene was characterized in a PM individual using exon-by-exon PCR-SSCP analysis. This allele, we termed CYP2D6(F), harbours four mutations including a new mutation (D6-F) which abolishes the splice acceptor site of the Ist intron and results in a premature stop codon, DNA samples from a large population of healthy unrelated volunteers were tested for D6-F using a PCR-assay we developed for the specific identification of the mutation in genomic DNA. The prevalence of D6-F was very low. However, its identification combined with that of the previously reported gene inactivating mutations would further increase the phenotype prediction rate by genotyping.
引用
收藏
页码:305 / 311
页数:7
相关论文
共 32 条
[1]   DEBRISOQUIN OXIDATION GENOTYPE AND SUSCEPTIBILITY TO LUNG-CANCER [J].
AGUNDEZ, JAG ;
MARTINEZ, C ;
LADERO, JM ;
LEDESMA, MC ;
RAMOS, JM ;
MARTIN, R ;
RODRIGUEZ, A ;
JARA, C ;
BENITEZ, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (01) :10-14
[2]   HYDROXYLATION POLYMORPHISMS OF DEBRISOQUINE AND MEPHENYTOIN IN EUROPEAN POPULATIONS [J].
ALVAN, G ;
BECHTEL, P ;
ISELIUS, L ;
GUNDERTREMY, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (06) :533-537
[3]   THE CYTOCHROME-P450 CYP2D6 ALLELIC VARIANT CYP2D6J AND RELATED POLYMORPHISMS IN A EUROPEAN POPULATION [J].
ARMSTRONG, M ;
FAIRBROTHER, K ;
IDLE, JR ;
DALY, AK .
PHARMACOGENETICS, 1994, 4 (02) :73-81
[4]  
BAER AN, 1986, ARTHRITIS RHEUM, V29, P137
[5]  
BROLY F, 1991, DNA CELL BIOL, V8, P545
[6]  
BROLY F, 1995, IN PRESS HUM GENET
[7]  
BROLY F, 1995, IN PRESS PHARMACOGEN
[8]   CYP2D6 GENOTYPE DETERMINATION IN THE DANISH POPULATION [J].
BROSEN, K ;
NIELSEN, PN ;
BRUSGAARD, K ;
GRAM, LF ;
SKJODT, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (03) :221-225
[9]   RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].
CAPORASO, N ;
LANDI, MT ;
VINEIS, P .
PHARMACOGENETICS, 1991, 1 (01) :4-19
[10]   LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE [J].
CAPORASO, NE ;
TUCKER, MA ;
HOOVER, RN ;
HAYES, RB ;
PICKLE, LW ;
ISSAQ, HJ ;
MUSCHIK, GM ;
GREENGALLO, L ;
BUIVYS, D ;
AISNER, S ;
RESAU, JH ;
TRUMP, BF ;
TOLLERUD, D ;
WESTON, A ;
HARRIS, CC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) :1264-1272